glp-1 obesity drug news october 21 2025 New Pill Foundayo (Orforglipron) Gets FDA Approval for Weight loss with GLP-1 medicines
Description
What is the difference between GLP-1 and GLP-1+GIP medications
A healthy diet and exercise also assist with weight loss
A key limitation for irisin translation remains the absence of a definitively identified receptor
d For the GLP-1 RA component only
Int J Environ Res Public Health
While effective, they come with notable side effects, including nausea, digestive issues and some serious issues : Vision Impairment Alert Semaglutide, a widely used GLP-1 receptor agonist, has been linked to a significantly higher rate of reported vision problems
